Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2010-01-14 Report Publication Anno…
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Phylogica`s 2010 Technical and Investor Presentations 1
Report Publication Announcement Classification · 95% confidence The document is a short announcement dated January 15, 2010, from Phylogica to the Australian Securities Exchange. It announces that the company's 2010 Technical and Investor Presentations are now available for download on their website. The text includes background information about the company and its technology but does not contain any financial data, detailed financial reports, or regulatory filings. The document is under 5,000 characters and primarily serves to inform investors about the availability of presentations rather than providing the presentations themselves or detailed financial information. Therefore, it fits the definition of a Report Publication Announcement (RPA), which is an announcement regarding the timing, release, or publication of company reports or presentations.
2010-01-14 English
RB Milestone Group - Research Report 1 page ?Kb
Report Publication Announcement Classification · 95% confidence The document is a short announcement (1315 characters) stating that a research report by RB Milestone Group has been prepared and is available on the company's website. It does not contain the report itself or any financial data, but merely informs shareholders and investors about the availability of the report. According to the 'Menu vs Meal' rule, this is an announcement about a report, not the report itself. Therefore, it should be classified as a Report Publication Announcement (RPA).
2009-12-21 English
Roche Agreement 3 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement dated December 21, 2009, from Phylogica Limited regarding the signing of an agreement with Roche. It describes the nature of the agreement and provides background information about the company and its technology. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is an announcement of a business agreement rather than a financial report or regulatory filing. It is not a report publication announcement since it does not mention the release or availability of a report. The content fits best under a general regulatory announcement category as it informs the market about a significant business development without financial data or management discussion. Therefore, the appropriate classification is Regulatory Filings (RNS).
2009-12-20 English
Appendix 3B 4 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new ordinary shares, including the number of shares, issue price, purpose of the issue (working capital), and dates related to the securities. It also includes a quotation agreement with the ASX (Australian Securities Exchange). The document references ASX rules and the Corporations Act, indicating it is a formal announcement related to capital raising and securities issuance. The content is consistent with a capital or financing update rather than a full financial report or other types of filings. The document length is about 6,000 characters, which is sufficient to contain substantive information about the new issue. Therefore, the appropriate classification is 'Capital/Financing Update' (CAP).
2009-12-17 English
Section 708A(5) notice 1 page ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is a notice given under Section 708A(5) of the Corporations Act regarding the issue of 20,000,000 ordinary fully paid shares pursuant to the 15% placement capacity under ASX listing rule 7.1. It confirms compliance with relevant provisions and provides information about the share issue without disclosure to investors under Part 6D.2 of the Corporations Act. This is an announcement related to a capital raising or share issuance event. The document length is short (1862 characters) and it is clearly an announcement of a share issue rather than a detailed financial report or other filing type. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2009-12-17 English
Phylogica Signs Agreement with Roche 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Phylogica has entered into an agreement with Roche to evaluate its proprietary technology. It discusses the nature of the collaboration and the technology involved but does not contain any financial data, regulatory filings, voting results, or detailed reports. It is not an annual report, earnings release, or any form of financial or regulatory filing. The content is primarily an announcement of a business collaboration or partnership. This type of document fits best under the category of a general regulatory announcement or miscellaneous filing that does not fit other specific categories, which corresponds to Regulatory Filings (RNS). The document length is 4342 characters, which is relatively short and consistent with a press release rather than a detailed report.
2009-12-17 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.